Levetiracetam Sandoz

Levetiracetam, the active ingredient in Levetiracetam Sandoz, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients with epilepsy, including partial‑onset, myoclonic, and primary generalized tonic‑clonic seizures, and is used across adult and pediatric populations under medical supervision.

GNH USA supplies Levetiracetam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this essential antiepileptic medication.

Levetiracetam is an antiepileptic medication that reduces abnormal neuronal firing in the brain.

Partial‑onset seizures: helps control focal seizures by decreasing neuronal excitability. Myoclonic seizures: reduces the frequency of sudden muscle jerks associated with epilepsy. Primary generalized tonic‑clonic seizures: diminishes the occurrence of convulsive episodes affecting the whole brain.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Fatigue or drowsiness - Dizziness or light‑headedness - Irritability or mood changes - Headache - Nausea or gastrointestinal discomfort

Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Blood dyscrasias (e.g., neutropenia, thrombocytopenia) - Multi‑organ hypersensitivity syndrome - Acute liver injury

When prescribing Levetiracetam, clinicians should consider several safety measures.

Dose adjustment: renal impairment may require dosage modification. Monitor: periodic assessment of mood and behavior changes. Avoid abrupt discontinuation: taper under medical guidance to prevent seizure worsening. Pregnancy: use only if potential benefit justifies risk; consult healthcare provider. Drug interactions: review concomitant medications for potential interactions. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital, or rifampin: strong enzyme inducers that markedly lower levetiracetam plasma levels. - St. John’s wort: may reduce exposure through enzyme induction.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations. - Lamotrigine: combined use may require monitoring for additive CNS effects. - Oral contraceptives: levetiracetam may slightly reduce hormonal efficacy; consider alternative contraception. - Alcohol: concurrent use can enhance central nervous system depression. - Other antiepileptics: monitor for cumulative side‑effect burden.